Autocrine regulation of airway smooth muscle responsiveness

Respiratory Physiology and Neurobiology

Volumn 137, Issue 2-3, 2003, Pages 263-276

  Hakonarson, Hakon ^a,b   Grunstein, Michael M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DECODE GENETICS   (Iceland)

Author keywords

Airway, inflammation, narrowing; Cytokines, airway smooth muscle, autocrine signaling; Disease, bronchial asthma; Mammals, humans; Muscle, smooth, airways

Indexed keywords

CHEMOKINE; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN E; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MESSENGER RNA;

ALLERGIC ASTHMA; AUTOCRINE EFFECT; BREATHING MUSCLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CELL REGENERATION; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; HUMAN; MAST CELL; MEMBRANE POTENTIAL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; RHINOVIRUS; SENSITIZATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SOUTHERN BLOTTING; UPREGULATION; VIRUS INFECTION;

EID: 0141792266     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9048(03)00152-6     Document Type: Article

References (112)

1. Arai K., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu. Rev. Biochem. 59:1990;783-836.
2. Bahna S.L., Horwitz C.A., Fiala M., Heiner D.C. IgE response in heterophil-positive infectious mononucleosis. J. Allergy Clin. Immunol. 62:1978;167-173.
3. Bardin P.G., Johnston S.L., Pattemore P.K. Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms. Clin. Exp. Allergy. 22:1992;809-822.
4. Barnes P.J., Chung K.F., Page C.P. Inflammatory mediators and asthma. Pharmacol. Rev. 40:1988;49-84.
5. Beasley R., Roche W.R., Roberts J.A., Holgate S.T. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:1989;806-817.
6. Beaven M.A., Metzger H. Signal transduction by Fc receptors: the FcεRI case. Immunol. Today. 14:1993;222-226.
7. Benhamou M., Siraganian R.P. Protein-tyrosine phosphorylation: an essential component of FcεRI signaling. Immunol. Today. 13:1992;195-197.
8. Berridge M.J. Inositol triphosphate and diacylglyceral: two interacting second messengers. Annu. Rev. Biochem. 56:1987;159-193.
9. Bochner B.S., Charleswoth E.N., Lichenstein L.M., et al. Interleukin-1 is released at site of human cutaneous allergic reactions. J. Allery Clin. Immunol. 86:1990;830-839.
10. Borish L., Mascali J.J., Rosenwasser L.J. IgE-dependent cytokine production by human cytokine production by human peripheral blood mononuclear phagocytes. J. Immunol. 146:1991;63.
11. Bradley L.M., Yoshimoto K., Swain S.L. The cytokines IL-4, IFN-γ, and IL-12 regulate the development of subsets of memory effector/helper T cells in vitro. J. Immunol. 155:1995;1713-1724.
12. Broide D.H., Lotz M., Cuomo A.J., Coburn D.A., Federman E.C., Wasserman S.I. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:1992;958-967.
13. Burd P.R., Rogers H.W., Gordon J.R., Martin C.A., Jayaraman S., Wilson S.D., Dvorak A.M., Galli S.J., Dorf M.E. Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J. Exp. Med. 170:1989;245-257.
14. Burka J.F., Saad M.H. Bronchodilator-mediated relaxation of normal and ovalbumin-sensitized guinea-pig airways: lack of correlation with lung adenylate cyclase activation. Br. J. Pharmacol. 83:1984;645-655.
15. Busse W.W. The relationship between viral infections and onset of allergic diseases and asthma. Clin. Exp. Allergy. 19:1989;1-9.
16. Busse W.W. Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma. J. Allergy Clin. Immunol. 85:1990;671-683.
17. Carty D.J., Padrell E., Codina J., Birnbaumer L., Hildebrandt J.D., Iyenger R.J. Distinct guanine nucleotide binding and release properties of the three Gi proteins. J. Biol. Chem. 265:1990;6268-6273.
18. Coffman R.L., Carty J. AT cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ J. Immunol. 136:1986;949-954.
19. Del Prete G.F., Maggi E., Parronchi P., Chreitien I., Jiri A., Macchia D., Ricci M., Banchereau J., De Vries J.E., Romagnani S. IL-4 is an essential co-factor for IgE synthesis induced in vitro by human T-cell clones and their supernatants. J. Immunol. 140:1988;4193-4198.
20. Dessaint J.P., Carpon A. Fc receptor II-positive macrophages and platlets: potent effector cells in allergy and defence against helminth parasites. Semin. Immunopathol. 12:1990;349.
21. Diaz P., Gonzalez M.C., Galleguillos F.R., Ancic P., Cromwell O., Shepherd D., Durham S.R., Gleich G.J., Kay A.B. Leukocytes and mediators in bronchoalveolar lavage during allergen-induced late-phase asthmatic reactions. Am. Rev. Respir. Dis. 139:1989;1383-1389.
22. Dinarello C.A. The interleukin-1 family: 10 years of discovery. FASEB J. 8:1984;1314-1325.
23. Dinarello C.A. Interleukin-1 and its biologically related cytokines. Adv. Immunol. 44:1989;153-205.
24. Djukanovic R., Roche W.R., Wilson J.W., Beasley C.R., Twentyman O.P., Howarth R.H., Holgate S.T. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:1990;434-457.
25. Dombrowicz D., Flamand V., Brigham K.K., Koller B.H., Kinet J.P. Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor α chain. Cell. 75:1993;969-976.
26. Ellis J.L., Walter C.H., Meeker S., Undem B. Ragweed antigen E and anti-IgE in Human central versus peripheral isolated bronchi. Am. J. Respir. Crit. Care Med. 150:1994;717-723.
27. Fischer E., van Zee K.J., Marano M.A., Rock C.S., Kenney J.S., Poutsiaka D.D., Dinarello C.A., Lowry S.F., Moldawer L.L. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood. 79:1992;2196-2200.
28. Fraenkel D.J., Bardin P.G., Sanderson G., Lampe F., Johnston S.L., Holgate S.T. Lower airways inflammation during rhinovirus colds in normal and asthmatic subjects. Am. J. Respir. Crit. Care Med. 151:1995;879-886.
29. Gagro A., Rabatic S., Trescec A., Dekaris D., Medar-Lasic M. Expression of lymphocytes FcεRII/CD23 in allergic children undergoing hyposensitization. Int. Arch. Allergy Immunol. 101:1993;203-208.
30. Galli S.J. New concepts about the mast cell. New Eng. J. Med. 328:1993;257-265.
31. Goldie R.G., Spina D., Henry P.J., Lulich K.M., Paterson J.W. In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, beta-adrenoceptor agonists and theophylline. Br. J. Clin. Pharmacol. 22:1986;669-676.
32. Greve J.M., Davis G., Meyer A.M., Forte C.P., Yost S.C., Marlor C.W., Kamarck M.E., McClelland A. The major human rhinovirus receptor is ICAM-1. Cell. 56:1989;839-847.
33. Griffin D.E., Cooper S.J., Hirsch R.L., Johnson R.T., Lindo de Soriano I., Roedenbeck S., Vaisberg A. Changes in plasma IgE levels during complicated and uncomplicated measles virus infections. J. Allergy Clin. Immunol. 76:1985;206-213.
34. Grunstein M.M., Hakonarson H., Hodinka R.L., Maskeri N., Kim C., Chuang S. Mechanism of cooperative effects of rhinovirus and atopic sensitization on airway responsiveness. Am. J. Physiol. Lung Cell. Mol. Physiol. 280:2001;L229-L238.
35. Grunstein M.M., Hakonarson H., Leiter J., Chen M., Whelan R., Grunstein J.S., Chuang S. Autocrine signaling by IL-10 mediates altered responsiveness of atopic sensitized airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 281:2001;L1130-L1137.
36. Grunstein M.M., Hakonarson H., Whelan R., Yu Z., Grunstein J.S., Chuang S. Rhinovirus elicits proasthmatic changes in airway responsiveness independently of viral infection. J. Allergy Clin. Immunol. 108:2001;997-1004.
37. Grunstein M.M., Hakonarson H., Leiter J., Chen M., Whelan R., Grunstein J.S., Chuang S. IL-13-dependent autocrine signaling mediates altered responsiveness of IgE-sensitized airway smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 282:2002;L520-L528.
38. Hakonarson H., Herrick D.J., Grunstein M.M. Mechanism of impaired β-adrenoceptor responsiveness in atopic sensitized airway smooth muscle. Am. J. Physiol. (Lung Cell. Mol. Physiol.). 269:1995;L645-L652.
39. Hakonarson H., Herrick D.J., Gonzalez-Serrano P., Grunstein M.M. Mechanism of cytokine-induced modulation of β-adrenoceptor responsiveness in airway smooth muscle. J. Clin. Invest. 97:1996;2593-2600.
40. Hakonarson H., Herrick D.J., Gonzalez-Serrano P., Grunstein M.M. Autocrine role of interleukin-1β in altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 99:1997;117-124.
41. Hakonarson H., Grunstein M.M. Regulation of second messengers associated with airway smooth muscle contraction and relaxation. Am. J. Respir. Crit. Care Med. 158:1998;115-122.
42. Hakonarson H., Grunstein M.M. Autologously upregulated Fc receptor expression and action in airway smooth muscle mediates its altered responsiveness in the atopic asthmatic sensitized state. Proc. Natl. Acad. Sci. USA. 95:1998;5257-5262.
43. Hakonarson H., Maskeri N., Carter C., Hodinka R., Campbell D., Grunstein M.M. Mechanism of rhinovirus-induced changes in airway smooth muscle responsiveness. J. Clin. Invest. 102:1998;1732-1741.
44. Hakonarson H., Carter C., Kim C., Grunstein M.M. Altered expression and action of the low-affinity IgE receptor, Fc(RII (CD23), in asthmatic airway smooth muscle. J. Allergy Clin. Immunol. 104:1999;575-584.
45. Hakonarson H., Carter C., Maskeri N., Hodinka R., Grunstein M.M. Rhinovirus-mediated changes in airway smooth muscle responsiveness: induced autocrine role of interleukin-1 beta. Am. J. Physiol. (Lung Cell Mol. Physiol.). 21):1999;L13-L21.
46. Hakonarson H., Carter C., Maskeri N., Kim C., Grunstein M.M. Regulation of TH1- and TH2-type cytokine expression and action in asthmatic sensitized airway smooth muscle. J. Clin. Invest. 103:1999;1077-1087.
47. Hakonarson H., Maskeri N., Kim C., Grunstein M. Autocrine interaction between IL-5 and IL-1β mediates altered responsiveness of atopic asthmatic sensitized airway smooth muscle. J. Clin. Invest. 104:1999;657-667.
48. Hamblin A.S. The role of cytokines in asthma. Ann. N.Y. Acad. Sci. 629:1991;250-261.
49. Hamid Q., Azzawi M., Sun Ying R., Moqbel A.J., Wardlaw C.J., Corrigan B., Bradley S., Durham R., Collins J.V., Jeffery P.K., Quint D.J., Kay A.B. Expression of mRNA for interleukin 5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1991;1541-1546.
50. Hessel E.M. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 16:1987;325-334.
51. Hirst, S.F., 2003. Regulation of airway smooth muscle cell immunomodulatory function: Role in asthma? Respir. Physiol. Neurobiol. Unpublished.
52. Johnson S.R., Knox A.J. Synthetic functions of airway smooth muscle in asthma. Trends Pharmacol. Sci. 18:1997;288-292.
53. Jordana M., Sarnstrand B., Sime P.J., Ramsis I. Immune-inflammatory functions of fibroblasts. Eur. Respir. J. 7:1994;2212-2222.
54. Joseph M., Tonnel A.B., Topier G., Capron A., Arnoux B., Benveniste J. Involvment of immunoglobulin E in the secretory processes of alveolar macrophages from asthmic patients. J. Clin. Invest. 71:1983;221.
55. Katada T., Kusakabe K., Oinuma M., Ui M. A novel mechanism for the inhibition of adenylate cyclase via inhibitory GTP-binding protein. J. Biol. Chem. 262:1987;11 897-11 900.
56. Kaziro Y., Itoh H., Kozassa T., Nakafuku M., Satoh T. Structure and function of signal-transducing GTP-binding proteins. Am. Rev. Biochem. 60:1991;349-400.
57. Kips J.C., Tavernier J., Pauwels R.A. Tumor necrosis factor (TNF) causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 145:1992;332-336.
58. Koning H., Neijens H.J., Baert M.R.M., Oranje A.P., Savelkoul H.F.J. T cell subsets and cytokines in allergic and non-allergic children. II. Analysis of IL-5 and IL-10 mRNA expression and protein production. Cytokine. 9:1997;427-436.
59. Lazaar A.L. Airway smooth muscle: new targets for asthma pharmacotherapy. Expert Opin. Ther. Targets. 6:2002;447-459.
60. Lemanske R.F., Dick E.C., Swenson C.A., Vrtis R.F., Busse W.W. Rhinovirus upper respiratory tract infection increases airway hyperreactivity and late asthmatic reactions. J. Clin. Invest. 83:1989;1-10.
61. Li J., Perrella M.A., Tsai J.C., Yet S.F., Hsieh C.M., Yoshizumi M., Patterson C., Endege W.O., Zhou F., Lee M.E. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem. 270:1995;308-312.
62. Litchfield T.M., Lee T.H. Asthma: cells and cytokines. J. Asthma. 29:(3):1992;181-191.
63. Lohmann-Matthes M.-L., Steinmuller C., Franke-Ullmann G. Pulmonary macrophages. Eur. Respir. J. 7:1994;1678-1689.
64. Lukacs N.W., Strieter R.M., Chensue S.W., Kunkel S.L. Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am. J. Respir. Cell Mol. Biol. 10:1994;526-532.
65. Mantovani A., Dejana E. Cytokines as communication signals between leukocytes and endothelial cells. Immunol. Today. 10:1989;370-375.
66. Mantovani A., Bussolino F., Dejana E. Cytokine regulation of endothelial cell function. FASEB J. 6:1992;2591-2599.
67. Martin M., Resch K. Interleukin 1: more than a mediator between leukocytes. Trends Pharmacol. Sci. 9:1988;171-177.
68. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Morgan W.J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N. Engl. J. Med. 332:1995;133-138.
69. Masinovsky B., Urdal D., Gallatin W.M. IL-4 acts synergistically with IL-1β to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J. Immunol. 145:1990;2886-2895.
70. Mattoli S., Mattoso V.L., Soloperto M., Allegra L., Dasoli A. Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J. Allergy Clin. Immunol. 87:1991;794-802.
71. McFadden E.R. Jr. Asthma: morphologic-physiologic interactions. Am. J. Respir. Crit. Care Med. 150:1994;523-526.
72. Mizel S.B. The interleukins. FASEB J. 3:1989;2379-2384.
73. Noah T.L., Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am. J. Physiol. 265:1993;L472-L478.
74. Ohno I., Yamauchi K., Takasihima T. Gene expression and production of tumor necrosis factor by a rat basophilic cell line (RBL2H3) with IgE receptor triggering. Immunology. 70:1990;88-93.
75. Paul W.E. Interleukin-4: a prototype immunoregalatory lymphokines. Blood. 77:1991;1859-1870.
76. Plaut M., Pierce J.H., Watson C.J., Hanley-Hyde J., Nordan R.P., Paul W.E. Mast cell lines produce lymphokines in response to cross-linkage of Fc-epsilon R1 or to calcium ionophores. Nature. 339:1989;64-67.
77. Pene J., et al. IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons, and prostaglandin E2. Proc. Natl. Acad. Sci. USA. 85:1988;6880-6884.
78. Phelan P.D., Landau L.I., Olinsky A. Respiratory Illness in Children. 2nd ed. 1982;34-37 Blackwell Scientific, Oxford.
79. Pujol J.L., Cosso B., Daures J.P., Clot J., Michel F.B., Godard P. Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. Int. Arch. Allergy Appl. Immunol. 91:1990;207-210.
80. Rabatic S., Gagro A., Medar-Lasic M. CD21-CD23 ligand pair expression in children with allergic asthma. Exp. Immunol. 94:1993;337-340.
81. Rizzo C.A., Yang R., Greenfeder S., Egan R.W., Pauwels R.A., Hey J.A. The IL-5 receptor on human bronchus selectively primes for hyperresponsiveness. J. Allergy Clin. Immunol. 109:2002;404-409.
82. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., Corrigan C., Durham S.R., Kay A.B. Predominant Th2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:1992;298-304.
83. Romagnani S. Human Th1 and Th2 subsets: 'Eppur si muove!'. Eur. Cytokine Netw. 5:1994;7-12.
84. Romagnani S. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15:1995;121-129.
85. Schleimer R.P., Sterbinsky S.A., Kaiser J., Bickel C.A., Klund D.A., Tomioka K., Newman W., Luscinskas F.W., Gimbrone M.A., McIntyre B.W., Bochner B.S. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J. Immunol. 148:1992;1086-1092.
86. Selig W., Tocker J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur. J. Pharmacol. 213:1992;331-336.
87. Shore, S.A., Moore, P.E., 2003. Regulation of b-adrenergic responses in airway smooth muscle. Respir. Physiol. Neurobiol. Unpublished.
88. Smith H. Animal models of asthma. Pulmonary Pharmacol. 2:1989;59-74.
89. Snapper C.M., Paul W.E. Interferon-γ and B cells stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 236:1987;944-947.
90. Stadnyk A.W. Cytokine production by epithelial cells. FASEB J. 8:1994;1041-1047.
91. Stark J.M., Graziano F.M. Lower airway responses to viruses. Busse W.W., Holgate S.T. Asthma and Rhinitis. 1995;1229-1243 Blackwell Scientific Publications, Boston, MA.
92. Subauste M.C., Jacoby D.B., Richards S.M., Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 96:1995;549-557.
93. Sylvester D.L., Raveth J.V. Fc receptors initiate Arthurs reaction: redefining the inflammatory cascade. Science. 265:1994;1095-1098.
94. Symons J.A., Young P.A., Duff G.W. The soluble interleukin-1 receptor: ligand binding properties and mechanisma of release. Lymphokine Cytokine Res. 12:1993;381.
95. Szentivanyi A. The beta-adrenergic theory of the atopic abnormality in bronchial asthma. J. Allergy. 42:1968;203-232.
96. Thompson A.B., Robbins R.A., Romberger D.J., Sisson J.H., Spurzem J.R., Teschler H., Rennard S.I. Immunological functions of the pulmonary epithelium. Eur. Respir. J. 8:1995;127-149.
97. Thornhill M.H., Wellicome S.M., Mahiouz D.L., Lanchbury J.S.S., Kyan-Aung U., Haskard D.O. Tumor necrosis factor combines with IL-4 or IFN-g to selectively enhance endothelial cell adhesiveness for T-cells. The contribution of vascular cell adhesion molecule-1-dependent and independent binding mechanisms. J. Immunol. 146:1991;592-598.
98. Tunon de Lara J.M., Okayama Y., Savineau J.-P., Marthan R. IgE-induced passive sensitization of human isolated bronchi and lung mast cells. Eur. Respir. J. 8:1995;1861-1865.
99. Ulich T.R., Watson L.R., Yin S.M., Guo K.Z., Wang P., Thang H., del Castillo J. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 receptor (IL-1) antagonist inhibits endotoxin- and IL-induced acute inflammation. Am. J. Pathol. 138:1991;521-524.
100. Umetsu D.T., de Kruyff R.E. Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases. Proc. Soc. Exp. Biol. Med. 215:1997;1-20.
101. Uncapher C.R., DeWitt C.M., Colonno R.J. The major and minor group receptor families contain all but one human rhinovirus serotype. Virology. 180:1991;814-817.
102. Vercelli D., Jabara H.H., Lee B.W., Woodland N., Geha R.S., Leung D.Y. Human recombinant interleukin 4 induces Fc RII/CD23 on normal human monocytes. J. Exp. Med. 167:1988;1406-1416.
103. Walker C., Bode E., Boer L., Hansel T.T., Blaser K., Virchow J.C. Allergic and non-allergic asthmatics have distinct pattern of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am. Rev. Respir. Dis. 146:1992;109-115.
104. Wanner A. Utility of animal models in the study of human airway disease. Chest. 98:1990;211-217.
105. Watson M.L., Smith D., Bourne A.D., Thompson R.C., Westwick J. Cytokines contribute to airway dyfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am. J. Respir. Cell Mol. Biol. 8:1990;365-369.
106. Wershil B.K., Wang K.S., Gordon J.R., Galli S.J. Recruitment of neutrophilis during IgE-dependent cutaneous late phase reaction in the mouse is mast cell dependent. J. Clin. Invest. 87:1991;446-453.
107. Wheeler A.P., Jesmok G., Brigham K.L. Tumor necrosis factor's effect on lung mechanics, gas exchange and airway reactivity in sheep. J. Appl. Physiol. 68:1993;153-159.
108. Williams J., Johnson S., Mascali J.J. Regulation of low affinity IgE receptor (CD23) expression on mononuclear phagocytes in normal and asthmatic subjects. J. Immunol. 149:1992;2823-2829.
109. Wills-Karp M., Gilmore M.I. Increased cholinergic antagonism underlies impaired beta-adrenergic response in ovalbumin sensitized guinea pigs. J. Appl. Physiol. 74:1993;2729-2735.
110. Wills-Karp M., Uchida Y., Lee J.Y., Jinot J., Hirata A., Hirata F. Organ culture with proinflammatory cytokines reproduces impairment of the β-adrenoceptor-mediated relaxation in tracheas of a guinea pig model. Am. J. Respir. Cell Mol. Biol. 8:1993;153-159.
111. Wishah K., Malur A., Raychaudhuri B., Melton A.L., Kavuru M.S., Thomassen M.J. Nitric oxide blocks inflammatory cytokine secretion triggered by CD23 in monocytes from allergic, asthmatic patients and healthy controls. Ann. Allergy Asthma Immunol. 89:2002;78-82.
112. Ying S., Durham S.R., Corrigan C.J., Hamid Q., Kay A.B. Phenotype of cells expressing mRNA for Th2-type (interleukins 4 and 5) and Th1-type (interleukin 2 and interferon-γ) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am. J. Respir. Cell Mol. Biol. 12:1995;477-487.